v3.24.1.u1
Condensed Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Gain/(Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   48,941,254      
Beginning balance at Dec. 31, 2022 $ 313,342 $ 5 $ 653,707 $ (1,958) $ (338,412)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued in a public offering, net of offering expenses (in shares)   9,583,334      
Common stock issued in a public offering, net of offering expenses 269,915 $ 1 269,914    
Issuance of common stock under benefit plans (in shares)   454,314      
Issuance of common stock under benefit plans 3,661   3,661    
Stock-based compensation expense 11,923   11,923    
Net unrealized (loss) gain on short-term investments 627     627  
Net loss (37,548)       (37,548)
Ending balance (in shares) at Mar. 31, 2023   58,978,902      
Ending balance at Mar. 31, 2023 $ 561,920 $ 6 939,205 (1,331) (375,960)
Beginning balance (in shares) at Dec. 31, 2023 59,921,002 59,921,002      
Beginning balance at Dec. 31, 2023 $ 473,576 [1] $ 6 972,973 345 (499,748)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under benefit plans (in shares)   397,540      
Issuance of common stock under benefit plans 1,879   1,879    
Stock-based compensation expense 9,666   9,666    
Net unrealized (loss) gain on short-term investments (834)     (834)  
Net loss $ (46,955)       (46,955)
Ending balance (in shares) at Mar. 31, 2024 60,318,542 60,318,542      
Ending balance at Mar. 31, 2024 $ 437,332 $ 6 $ 984,518 $ (489) $ (546,703)
[1] The condensed balance sheet as of December 31, 2023 has been derived from the audited financial statements as of that date.